Project Grant HT94252410996
Award Date
11/1/24
Completion Date
10/31/28
Dollars Obligated
$2.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
The University of New South Wales (UNSW) was awarded a $5,835,803 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from March 1, 2025 to February 28, 2029, supports the development of a comprehensive breast cancer cellular atlas. This research project aims to advance disease prevention, diagnosis, treatment, and management through basic, applied, and translational research...
The University of New South Wales received a $555,506.43 three-year Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund a study titled "DUAL EPITHELIAL AND STROMAL TARGETING IN BREAST CANCER USING THE PHASE II ROCK2 INHIBITOR KD025 GUIDED BY INTRAVITAL IMAGING TECHNOLOGY" from March 1, 2022 to February 28, 2025. Through this award, the University will conduct research into investigating...
This $125,050 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of New South Wales (UNSW) to investigate the use of UDP-glucose in inducing ovarian cancer cell death and promoting antitumor immunity. The research aims to advance the understanding of therapeutic approaches for ovarian cancer, with the ultimate completion date of June 30, 2026. As a leading Australian research...
The U.S. Defense Health Agency awarded a $437,975 Project Grant to the University of New South Wales, doing business as The University of NSW, to conduct research on "TARGETING THE NOVEL LONG NONCODING RNA PRKCQ-AS1 FOR CANCER THERAPY". This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for U.S. Service Members and the public. The funded research aims...
The University of Sydney was awarded a $632,080 federal Project Grant under the Military Medical Research and Development (CFDA 12.420) program by the Defense Health Agency. The grant will fund research to investigate what endows women with a better chance of survival from melanoma, with a performance period from July 1, 2025 to June 30, 2028. The advanced biomedical research project aims to transform healthcare for military service members and the broader public by advancing disease prevention,...
The University of Queensland in Australia was awarded a $1,488,596 Project Grant from the Department of the Army Medical Command to support melanoma research from September 2022 through September 2025. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health issues. Under this award, The University of Queensland...
The Defense Health Agency awarded a $744,997 Project Grant to the University of Queensland in Australia under the Military Medical Research and Development program (CFDA 12.420). This grant, titled "DISCOVERING THERAPEUTIC VULNERABILITIES OF CIRCULATING MELANOMA CLUSTERS," provides funding for the university to conduct cutting-edge biomedical research on melanoma from June 1, 2024 through May 31, 2027. The University of Queensland, a leading research institution in Australia, has an...
The University of Queensland in Australia was awarded a $744,744 USD project grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "Understanding the Role of Immature Myeloid Cells in Early Melanoma Establishment" from September 30, 2022 to September 29, 2025. Through this funding, researchers at The University of Queensland will investigate the role of immature myeloid...
The Department of the Army Medical Command awarded $608,341 to Monash University under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2022 through September 14, 2025. The project grant funding will support Monash University's research efforts to elucidate and suppress cells of origin of cutaneous melanoma. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
The Defense Health Agency awarded a $4,319,388 Project Grant to the University of Melbourne to fund research aimed at "TARGETING SENESCENT CELLS TO IMPROVE OUTCOMES FOR BREAST CANCER PATIENTS" over the period from September 1, 2024 to August 31, 2028. This grant is provided under the Military Medical Research and Development Program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...